GSK plc has received Orphan Drug Designation in Japan for its investigational antibody-drug conjugate risvutatug rezetecan (Ris-Rez) for the treatment of small-cell lung cancer, supported by early ...
Tokyo considering alternate sources of energy, including from Kazakhstan, Azerbaijan as well as Australia - Anadolu Ajansı ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results